ClinicalTrials.Veeva

Menu

Oral Microbioma and Oral Malignant Disease

A

Academisch Ziekenhuis Maastricht

Status

Enrolling

Conditions

Oral Squamous Cell Carcinoma
Oral Cancer
Premalignant Lesion

Study type

Observational

Funder types

Other

Identifiers

NCT05766150
METC 2019-1251

Details and patient eligibility

About

This case-control study aims to investigate if oral microbioma is associated with developing oral (pre)malignant disease.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients ≥18 years in case of oral malignancy or premalignant disease, ≥40 years in case of no malignant disease
  • Patients are (partially) dentate (≥20 teeth)
  • Patients who have given written informed consent to participate in this study

Exclusion criteria

  • Patients with a history of radiotherapy in head and neck region
  • Patients with a history of chemotherapy, immunotherapy or immunomodulating drugs
  • Patients with a previous malginancy in head and neck region
  • Edentulous patients (with or without implants)
  • Patients with removable (partial) dentures

Trial design

300 participants in 3 patient groups

Patients with no oral malignant disease
Patients with oral premalignant disease
Patients with oral malignant disease

Trial contacts and locations

2

Loading...

Central trial contact

L.A.A. Vaassen; E.R.C. Hagens

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems